A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Oxybuprocaine
Tiotropium
The risk or severity of Tachycardia can be increased when Ephedrine is combined with Tiotropium.
Oxybuprocaine
Metocurine
The risk or severity of Tachycardia can be increased when Metocurine is combined with Ephedrine.
Oxybuprocaine
Diphenidol
The risk or severity of Tachycardia can be increased when Diphenidol is combined with Ephedrine.
Oxybuprocaine
Mivacurium
The risk or severity of Tachycardia can be increased when Mivacurium is combined with Ephedrine.
Oxybuprocaine
Orphenadrine
The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Ephedrine.
Oxybuprocaine
Cilostazol
The risk or severity of Tachycardia can be increased when Cilostazol is combined with Ephedrine.
Oxybuprocaine
Flavoxate
The risk or severity of Tachycardia can be increased when Flavoxate is combined with Ephedrine.
Oxybuprocaine
Oxybutynin
The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Ephedrine.
Oxybuprocaine
Tolterodine
The risk or severity of Tachycardia can be increased when Tolterodine is combined with Ephedrine.
Oxybuprocaine
Glycopyrronium
The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Ephedrine.
Oxybuprocaine
Cycrimine
The risk or severity of Tachycardia can be increased when Cycrimine is combined with Ephedrine.
Oxybuprocaine
Methantheline
The risk or severity of Tachycardia can be increased when Methantheline is combined with Ephedrine.
Oxybuprocaine
Maprotiline
The risk or severity of Tachycardia can be increased when Maprotiline is combined with Ephedrine.
Oxybuprocaine
Bretylium
The therapeutic efficacy of Ephedrine can be decreased when used in combination with Bretylium.
Oxybuprocaine
ORM-12741
ORM-12741 may decrease the hypertensive activities of Ephedrine.
Oxybuprocaine
Buflomedil
Ephedrine may decrease the hypertensive activities of Buflomedil.
Oxybuprocaine
Idazoxan
Ephedrine may decrease the hypertensive activities of Idazoxan.
Oxybuprocaine
Naftopidil
Ephedrine may decrease the hypertensive activities of Naftopidil.
Oxybuprocaine
Atipamezole
Ephedrine may decrease the hypertensive activities of Atipamezole.
Oxybuprocaine
Moxisylyte
Ephedrine may decrease the hypertensive activities of Moxisylyte.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3